Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2021 - 2028

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2021 - 2028

Viscosupplementation Market Growth & Trends

The global viscosupplementation market size is expected to reach USD 7.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.37% from 2021 to 2028. Initiatives to increase awareness regarding available treatment, the rising geriatric population, and product advancements are expected to boost market growth during the forecast period. With the growing geriatric population, the burden of osteoarthritis is expected to increase dramatically. As per the Arthritis Foundation, in the U.S., around 54.4 million adults are reported to be diagnosed with doctor-diagnosed arthritis.

Favorable reimbursement policies with respect to the geriatric population are expected to act as an opportunity for market growth. The viscosupplementation business was affected due to the COVID-19 pandemic as many healthcare providers postponed the nonessential patient visits, such as osteoarthritis treatments. Although ease in COVID-19 restrictions regarding surgeries led to a recovery in surgery volume, certain markets, such as Spain, the U.K., and Italy witnessed a low pace of recovery. Asia Pacific held the largest revenue share of the global market in 2020.

In recent years, exponential growth in the number of orthopedic surgeons in developing countries, such as South Korea, Russia, and China, was observed. Asia Pacific region presents high growth potential owing to large patient population and untapped opportunities in comparison with the U.S. Therefore, the introduction of products by the players in Asian countries is further expected to propel the market growth. In July 2017, Anika Therapeutics announced regulatory approval of MONOVISC in India followed by approval in Australia in October 2017.

However, such strategic initiatives were offset to some extent by the impact of the COVID-19 pandemic, which led to the disruption of company operations. Europe is expected to register the fastest CAGR during the forecast period. This can be attributed to a large number of clinical trials being conducted in the region to provide efficient treatment for knee osteoarthritis with the help of stem cells.

Viscosupplementation Market Report Highlights

  • Single-injection led the type segment in 2020 and is expected to register the fastest growth rate over the forecast period due to various factors, such as new product launch and affordability as compared to their counterparts
  • For instance, in March 2019, SeikagakuCorp. launched an intra-articular single injection viscosupplement “HyLink” for the therapy of knee osteoarthritis in Italy
  • The orthopedic clinics/ASC send-use segment is expected to exhibit the fastest CAGR during the forecast period. The increasing prevalence of osteoarthritis among the geriatric population is one of the major factors expected to contribute to the segment growth
  • Collaborations for development & expansion of product portfolios and geographical expansion in emerging markets are key strategies adopted by companies to increase their market share
  • For instance, in June 2020, Seikagaku Corporation completed acquiring all shares of Dalton Chemical Laboratories, Inc., an unlisted company in Canada
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Report Scope and Objectives
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.1.2 Purchased Database
2.1.3 GVR’s Internal Database
2.1.4 Secondary Sources
2.1.5 Primary Research
2.2 Information or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis
2.5 List of Secondary Sources
2.6 List of Abbreviations
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product
3.2.2 End use
3.3 Regional Outlook
3.4 Competitive Insights
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Related/Ancillary Market Outlook
4.2 Viscosupplementation Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Increasing prevalence of osteoarthritis among geriatric population
4.2.1.2 New product development
4.2.2 Market Restraint Analysis
4.2.2.1 High cost of products
4.2.2.2 Side effects associated with hyaluronic acid cycles
4.3 Viscosupplementation Market: Business Environment Analysis Tools
4.3.1 PESTLE Analysis
4.3.1.1 Political & legal
4.3.1.2 Economic & social
4.3.1.3 Technological
4.3.2 Porter’s five forces analysis
4.3.2.1 Threat of new entrants: Low
4.3.2.2 Bargaining power of buyers: Moderate
4.3.2.3 Competitive rivalry: High
4.3.2.4 Threat of substitutes: Moderate
4.3.2.5 Bargaining power of suppliers: High
4.4 Penetration & Growth Prospect Mapping
4.5 Clinical Trials
4.6 Major Deals & Strategic Alliances Analysis
4.6.1 Mergers & Acquisitions
4.6.2 Licensing & partnerships, technology collaborations
4.7 Product Pricing Analysis
4.7.1 North America
4.7.2 Europe
4.7.3 Asia Pacific
4.7.4 Latin America
4.7.5 Middle east & Africa
4.8 Distribution Channel Analysis
4.8.1 Distribution and marketing rights of Viscosupplements
4.8.2 North America
4.8.3 Europe
4.8.4 Asia Pacific
4.8.5 Latin America
4.8.6 Middle East & Africa
4.9 Impact of COVID-19 on Viscosupplementation Market
Chapter 5 Viscosupplementation Market: Product Analysis
5.1 Viscosupplementation Market: Product Movement Analysis, 2020 & 2028
5.2 Viscosupplementation Product Market: Segment Dashboard
5.2.1 Single Injection
5.2.1.1 Single injection market, 2016-2028 (USD Million)
5.2.2 Three Injection
5.2.2.1 Three injection market, 2016-2028 (USD Million)
5.2.3 Five Injection
5.2.3.1 Five injection market, 2016-2028 (USD Million)
5.2.4 Product Information
5.2.4.1 Durolane
5.2.4.2 GelSyn-3
5.2.4.3 GenVisc 850
5.2.4.4 Hymovis
5.2.4.5 Supartz FX
5.2.4.6 TriVisc
5.2.4.7 Visco-3
5.2.4.8 Ostenil
5.2.4.9 Adant
Chapter 6 Viscosupplementation Market: End-use Analysis
6.1 Viscosupplementation Market: End Use Movement Analysis, 2020 & 2028
6.2 Viscosupplementation End Use Market: Segment Dashboard
6.2.1 Hospitals
6.2.1.1 Hospitals market, 2016-2028 (USD Million)
6.2.2 Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
6.2.2.1 Orthopedic clinics/ambulatory surgical centers (ASCs) market, 2016-2028 (USD Million)
Chapter 7 Viscosupplementation Market: Regional Analysis
7.1 Regional Movement Analysis & Market Share, 2020 & 2028
7.2 SWOT Analysis, by Factor
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East and Africa
7.3 North America
7.3.1 North America viscosupplementation Market, 2016 - 2028 (USD Million)
7.3.2 The U.S.
7.3.2.1 Regulatory and reimbursement scenario
7.3.2.2 The U.S. viscosupplementation market, 2016 - 2028 (USD Million)
7.3.3 Canada
7.3.3.1 Regulatory and reimbursement scenario
7.3.3.2 Canada viscosupplementation market, 2016 - 2028 (USD Million)
7.4 Europe
7.4.1 Europe viscosupplementation market, 2016 - 2028 (USD Million)
7.4.2 The U.K.
7.4.2.1 Regulatory and reimbursement scenario
7.4.2.2 The U.K. viscosupplementation market, 2016 - 2028 (USD Million)
7.4.3 Germany
7.4.3.1 Regulatory and reimbursement scenario
7.4.3.2 Germany viscosupplementation market, 2016 - 2028 (USD Million)
7.4.4 France
7.4.4.1 Regulatory and reimbursement scenario
7.4.4.2 France viscosupplementation market, 2016 - 2028 (USD Million)
7.4.5 Italy
7.4.5.1 Regulatory and reimbursement scenario
7.4.5.2 Italy viscosupplementation market, 2016 - 2028 (USD Million)
7.4.6 Spain
7.4.6.1 Regulatory and reimbursement scenario
7.4.6.2 Spain viscosupplementation market, 2016 - 2028 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific viscosupplementation market, 2016 - 2028 (USD Million)
7.5.2 China
7.5.2.1 Regulatory and reimbursement scenario
7.5.2.2 China viscosupplementation market, 2016 - 2028 (USD Million)
7.5.3 Japan
7.5.3.1 Regulatory and reimbursement scenario
7.5.3.2 Japan viscosupplementation market, 2016 - 2028 (USD Million)
7.5.4 India
7.5.4.1 Regulatory and reimbursement scenario
7.5.4.2 India viscosupplementation market, 2016 - 2028 (USD Million)
7.5.5 South Korea
7.5.5.1 Regulatory and reimbursement scenario
7.5.5.2 South Korea viscosupplementation market, 2016 - 2028 (USD Million)
7.5.6 Australia
7.5.6.1 Regulatory and reimbursement scenario
7.5.6.2 Australia viscosupplementation market, 2016 - 2028 (USD Million)
7.6 Latin America
7.6.1 Regulatory and reimbursement scenario
7.6.2 Latin America viscosupplementation market, 2016 - 2028 (USD Million)
7.6.3 Brazil
7.6.3.1 Regulatory and reimbursement scenario
7.6.3.2 Brazil viscosupplementation market, 2016 - 2028 (USD Million)
7.6.4 Mexico
7.6.4.1 Regulatory and reimbursement scenario
7.6.4.2 Mexico viscosupplementation market, 2016 - 2028 (USD Million)
7.6.5 Argentina
7.6.5.1 Regulatory and reimbursement scenario
7.6.5.2 Argentina viscosupplementation market, 2016 - 2028 (USD Million)
7.6.6 Colombia
7.6.6.1 Colombia viscosupplementation market, 2016 - 2028 (USD Million)
7.7 Middle East & Africa
7.7.1 Middle East & Africa viscosupplementation market, 2016 - 2028 (USD Million)
7.7.2 South Africa
7.7.2.1 Regulatory and reimbursement scenario
7.7.2.2 South Africa viscosupplementation market, 2016 - 2028 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Regulatory and reimbursement scenario
7.7.3.2 Saudi Arabia viscosupplementation market, 2016 - 2028 (USD Million)
7.7.4 UAE
7.7.4.1 UAE viscosupplementation market, 2016 - 2028 (USD Million)
Chapter 8 Reimbursement Outlook
8.1 Direct Medical Cost of Treatment of Osteoarthritis (Percentage Distribution)
8.2 Reimbursement by Product
8.2.1 Gel - one
8.2.2 Euflexxa
8.2.3 Synvisc - one
8.2.4 Supartz
8.2.5 Hyalgan
8.2.6 Monovisc
8.2.7 Orthovisc
Chapter 9 Competitive Landscape
9.1 Recent Development & Impact Analysis by Key Market Participants
9.2 Competition Categorization
9.3 Company Market Position Analysis
9.4 Company Profiles
9.4.1 Sanofi
9.4.1.1 Company overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.1.5 SWOT analysis
9.4.2 Anika Therapeutics, Inc.
9.4.2.1 Company overview
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.2.5 SWOT analysis
9.4.3 SEIKAGAKU CORPORATION
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.3.5 SWOT analysis
9.4.4 Zimmer Biomet
9.4.4.1 Company overview
9.4.4.2 Financial performance
9.4.4.3 Product benchmarking
9.4.4.4 Strategic initiatives
9.4.4.5 SWOT analysis
9.4.5 Smith & Nephew PLC
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.5.5 SWOT analysis
9.4.6 Ferring Pharmaceutical B.V.
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 Lifecore Biomedical, LLC (Landec)
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.7.5 SWOT analysis
9.4.8 LG Life Sciences Ltd.
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.8.5 SWOT analysis
9.4.9 Fidia Farmaceutici S.p.A
9.4.9.1 Company overview
9.4.9.2 Financial performance
9.4.9.3 Product benchmarking
9.4.9.4 Strategic initiatives
9.4.10 F.Hoffmann-La Roche Ltd.
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives
9.4.10.5 SWOT analysis
Chapter 10 Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings